Search Results

You are looking at 1 - 2 of 2 items for :

  • Editor's Choice x
  • Open access x
Clear All
Open access

John W Cassidy, Ankita S Batra, Wendy Greenwood, and Alejandra Bruna

-specific phenotypes and those that resemble human malignancies ( Cardiff et al. 2000 ). The choice of gene promoter and the mechanism of induction greatly influence the histological phenotype of the resulting tumour, and this needs to be taken into consideration for

Open access

Simon Linder, Henk G van der Poel, Andries M Bergman, Wilbert Zwart, and Stefan Prekovic

-sensitive setting. Similarly, enzalutamide is a first-line option for symptomatic men who received docetaxel in the castration-naïve setting; whereas either docetaxel, abiraterone or enzalutamide treatment are the therapies of choice for symptomatic patients who did